<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Insulin_aspart</id>
	<title>Insulin aspart - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Insulin_aspart"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Insulin_aspart&amp;action=history"/>
	<updated>2026-04-16T19:38:03Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=Insulin_aspart&amp;diff=4967428&amp;oldid=prev</id>
		<title>Prab at 12:19, 9 September 2023</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Insulin_aspart&amp;diff=4967428&amp;oldid=prev"/>
		<updated>2023-09-09T12:19:37Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[Insulin aspart]] is a rapid-acting form of [[insulin]] primarily used in the treatment of [[diabetes mellitus]] to control blood sugar levels.&lt;br /&gt;
[[File:Insulin Aspart Structural Formula.gif|Insulin Aspart Structural Formula|thumb]]&lt;br /&gt;
=== Brand Names ===&lt;br /&gt;
&lt;br /&gt;
This form of insulin is commercially known under the brand names &amp;#039;&amp;#039;&amp;#039;Novolog&amp;#039;&amp;#039;&amp;#039; in the United States and &amp;#039;&amp;#039;&amp;#039;NovoRapid&amp;#039;&amp;#039;&amp;#039; in some other countries.&lt;br /&gt;
&lt;br /&gt;
=== Mechanism of Action ===&lt;br /&gt;
&lt;br /&gt;
Insulin aspart begins to work shortly after injection, typically showing its effects within minutes. This rapid onset allows it to closely mimic the insulin spikes that a healthy pancreas would release in response to food intake. As a result, it can be administered shortly before or after meals, offering flexibility in dosing relative to meal times.&lt;br /&gt;
&lt;br /&gt;
=== FDA Approval ===&lt;br /&gt;
&lt;br /&gt;
The [[Food and Drug Administration]] (FDA) granted approval for insulin aspart in June 2000, allowing it to be prescribed and sold in the United States.&lt;br /&gt;
&lt;br /&gt;
=== Administration and Dosing ===&lt;br /&gt;
&lt;br /&gt;
The key advantage of insulin aspart over traditional insulins is its flexibility in dosing. Patients can adjust the quantity of the drug based on their meal intake, making it easier to manage and control blood sugar levels in real-time. This tailoring of doses allows for more precise blood sugar control, reducing the risks of both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar).&lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
* [[Diabetes mellitus]]&lt;br /&gt;
* [[Insulin]]&lt;br /&gt;
* [[Blood sugar level]]&lt;br /&gt;
* [[Food and Drug Administration]]&lt;br /&gt;
{{stub}}&lt;br /&gt;
{{Oral hypoglycemics and insulin analogs}}&lt;br /&gt;
{{Portal bar | Medicine}}&lt;br /&gt;
{{DEFAULTSORT:Insulin Aspart}}&lt;br /&gt;
[[Category:Insulin receptor agonists]]&lt;br /&gt;
[[Category:Insulin therapies]]&lt;br /&gt;
[[Category:Diabetes]]&lt;br /&gt;
[[Category:Human proteins]]&lt;br /&gt;
[[Category:Recombinant proteins]]&lt;br /&gt;
[[Category:Peptide hormones]]&lt;br /&gt;
[[Category:Diabetes mellitus]]&lt;br /&gt;
[[Category:Drugs]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>